While all tumors showed CTLA-4 positivity, the intensity of staining varied from weak and/or strong between early (stages I and II) and late stages (stages III and IV) of cancer and within the same stage, demonstrating heterogeneous expression. The gene discussed is CTLA4; the disease is cancer.